Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cardiff Oncology logo — Cardiff Oncology is a clinical-stage company with the missio...

Cardiff Oncology

Cardiff Oncology is a clinical-stage company with the mission of developing new treatment options for cancer patients.

Founded 1999 United States San Diego, United States 54 employees

General Information

Company Name Cardiff Oncology
Founded Year 1999
Location United States San Diego, United States +1
Employees 54
Social

Get notified when Cardiff Oncology moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cardiff Oncology

Cardiff Oncology is a clinical-stage biotechnology company, headquartered in San Diego, CA, leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. Our lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard-of-care (SoC) therapeutics in clinical programs targeting indications such as KRAS/NRAS-mutated metastatic colorectal cancer (mCRC) and metastatic pancreatic ductal adenocarcinoma (mPDAC), as well as in investigator-initiated trials in triple negative breast cancer (TNBC) and small cell lung cancer (SCLC). These programs and Cardiff's broader development strategy are designed to target tumor vulnerabilities in order to overcome treatment resistance and deliver superior clinical benefit compared to the SoC alone. For more information, please visit https://www.cardiffoncology.com.

No funding data available for Cardiff Oncology yet.

Get notified when Cardiff Oncology raises funding

Cardiff Oncology Alternatives & Competitors

Cardiff Oncology vs
Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals United States

Advancing patient healthcare with innovative molecular imaging and targeted radiotherapeutics in onc...

2 employees
Biotechnology, Health Care
Cardiff Oncology vs
Alpha-9 Oncology
Alpha-9 Oncology United States

Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and high...

33 employees
Cardiff Oncology vs
Vuja De Sciences
Vuja De Sciences

Vuja De is dedicated to developing cancer metastasis treatments that prevent cancer progression and...

Series Unknown
7 employees
Biotechnology, Health Care

FAQ About Cardiff Oncology

Cardiff Oncology is a clinical-stage company with the mission of developing new treatment options for cancer patients.
Cardiff Oncology was founded in 1999.
Cardiff Oncology is headquartered in San Diego, United States.
Cardiff Oncology has approximately 54 employees.
Top alternatives and competitors to Cardiff Oncology include Molecular Insight Pharmaceuticals, Alpha-9 Oncology, Vuja De Sciences, Cybrexa Therapeutics, Oxford BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiff Oncology and Molecular Insight Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cardiff Oncology and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy